Maxalt and Latuda drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Maxalt (rizatriptan benzoate) and Latuda (lurasidone hydrochloride). Common drug interactions include fall among females and akathisia among males.

The phase IV clinical study analyzes what interactions people have when they take Maxalt and Latuda. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Maxalt?

Maxalt has active ingredients of rizatriptan benzoate. It is often used in migraine. eHealthMe is studying from 12,754 Maxalt users. Check the latest studies of Maxalt.

What is Latuda?

Latuda has active ingredients of lurasidone hydrochloride. It is often used in bipolar disorder. eHealthMe is studying from 21,543 Latuda users. Check the latest studies of Latuda.

On Jul, 28, 2026

44 people who take Maxalt and Latuda together, and have interactions are studied.

What are the common drug interactions of Maxalt and Latuda, by gender? *:

female:

Fall
Neuropathy peripheral (surface nerve damage)
Weight increased
Chronic kidney disease
Clavicle fracture
Dyspepsia (indigestion)
Hypotension (abnormally low blood pressure)
Plague
Therapeutic response unexpected
Ankle fracture

male:

Akathisia (a movement disorder characterized by a feeling of inner restlessness)
Anxiety
Blood potassium decreased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Dehydration (dryness resulting from the removal of water)
Dyskinesia (abnormality or impairment of voluntary movement)
Headache (pain in head)
Insomnia (sleeplessness)
Myalgia (muscle pain)
Urinary tract infection

What are the common drug interactions of Maxalt and Latuda, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Fall
Ankle fracture
Clavicle fracture
Lower limb fracture
Muscle twitching
Abdominal pain upper
Gallbladder operation
Muscle spasms (muscle contraction)
Irritable bowel syndrome
Nephrolithiasis (calculi in the kidneys)

40-49:

Pain
Suicide attempt
Weight increased
Chronic kidney disease
Hypoglycaemia (deficiency of glucose in the bloodstream)

50-59:

Anxiety
Disease recurrence
Dysphagia (a condition in which swallowing is difficult or painful)
Dyspnoea (difficult or laboured respiration)
Formication (a sensation that exactly resembles that of small insects crawling on (or under) the skin)
Panic attack
Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)

60+:

Chronic kidney disease
Aggression
Renal failure (kidney dysfunction)
Renal injury (kidney injury)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Ammonia increased
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Carbon dioxide increased
Catatonia (unresponsive to external stimuli)
Confusional state

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 28 people, 63.64%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 8 people, 18.18%
Pain: 5 people, 11.36%
Fibromyalgia (a long-term condition which causes pain all over the body): 5 people, 11.36%
Depression: 4 people, 9.09%
Headache (pain in head): 3 people, 6.82%

* Approximation only. Some reports may have incomplete information.

Do you take Maxalt and Latuda?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously